| Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673) |
|---|
| 05/21/2004 | WO2004041162A2 Inhibitors of akt activity |
| 05/21/2004 | WO2004005406A3 Charge transport compositions on the basis of triarylmethanes and their use in electronic devices |
| 05/20/2004 | US20040097734 Aryl- and heteroarylcarbonylpiperazines and their use for the treatment of benign and malignant oncoses |
| 05/20/2004 | US20040097730 Amide containing a pyridinone or pyrazinone compound as serine protease enzyme inhibitors |
| 05/20/2004 | US20040097725 Charge transport compositions and electronic devices made with such compositions |
| 05/20/2004 | US20040097594 Sulfonamide inhibitors of aspartyl protease |
| 05/20/2004 | US20040097554 For therapy and prophylaxis of autoimmune diseases, acute and chronic inflammatory conditions, allergic conditions, infection associated with inflammation, viral inflammation, transplantation tissue rejection, atherosclerosis, restenosis |
| 05/20/2004 | US20040097550 For therapy of thrombosis, myocardial infarction, arteriosclerosis, inflammation, apoplexia, angina pectoris, restenosis after angioplasty, claudicatio intermittens, tumours, tumour diseases and/or tumour metastases |
| 05/20/2004 | US20040097508 Novel heterocyclically substituted amides, their preparation and use |
| 05/20/2004 | US20040097496 Novel thiazine derivatives |
| 05/20/2004 | US20040097487 To inhibits matrix metalloprotease activity |
| 05/19/2004 | EP1419773A2 4-Phenylpiperidine derivatives as modulators of dopamine neurotransmission |
| 05/19/2004 | EP1034164B1 Substituted beta-alanine derivatives as cell adhesion inhibitors |
| 05/19/2004 | EP1025102B1 Bicyclic kinase inhibitors |
| 05/19/2004 | EP1020453B1 6,7-asymmetrically disubstituted quinoxalinecarboxylic acid derivatives, addition salts thereof, and processes for the preparation of both |
| 05/19/2004 | EP0975682B1 Group 8-10 transition metal olefin polymerization catalysts |
| 05/19/2004 | DE10250708A1 Neue Alkin-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel New alkyne compounds with MCH-antagonistic activity and pharmaceutical compositions containing them |
| 05/19/2004 | CN1498210A MCH antagonists and their use in treatment of obesity |
| 05/19/2004 | CN1498206A Biurethane derivatives |
| 05/18/2004 | US6737423 Substituted heterocyclo-norbornylamino derivatives, processes for their preparation, their use as medicaments or diagnostics, and medicaments comprising them |
| 05/18/2004 | US6737193 Tetraketopiperazine unit-containing compound as an active material in batteries |
| 05/13/2004 | WO2004039787A1 Heteroaryl-hexanoic acid amide derivatives as immunomodulatory agents |
| 05/13/2004 | WO2004039780A1 Novel alkyne compounds having an mch antagonistic effect and medicaments containing these compounds |
| 05/13/2004 | WO2004039753A2 Phenyl compounds |
| 05/13/2004 | WO2004026305A9 Diaryl ethers as opioid receptor antagonist |
| 05/13/2004 | US20040092747 Amide compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use |
| 05/13/2004 | US20040092687 Polymeric charge transport compositions and electronic devices made with such compositions |
| 05/13/2004 | US20040092521 Antihistamines; central nervous system disorders |
| 05/13/2004 | US20040092508 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance |
| 05/13/2004 | US20040092401 Plant safening agents |
| 05/13/2004 | CA2503770A1 Heteroaryl-hexanoic acid amide derivatives as immunomodulatory agents |
| 05/12/2004 | EP1244638B1 Phenanthryl piperazinyl dicarboxylic acids as selective nmda receptor modulating agents |
| 05/12/2004 | EP1028111B1 Amide derivatives or salts thereof |
| 05/12/2004 | EP1015429B1 Benzimidazolinones, benzoxazolinones, benzopiperazinones, indanones, and derivatives thereof as inhibitors of factor xa |
| 05/12/2004 | CN1149081C Arylsubstituted piperazines useful in the threatement of bening prostatic hyperlasia |
| 05/11/2004 | US6734203 Fused imidazolium derivatives |
| 05/11/2004 | US6734184 Arylpiperazines and their use as metalloproteinase inhibiting agents (MMP) |
| 05/11/2004 | US6734183 Useful as metalloproteinase inhibitor; piperazino-sulfonamide or piperidino-sulfonamide compound |
| 05/11/2004 | US6734182 Aryl sulfonamides and sulfamide derivatives and uses thereof |
| 05/06/2004 | WO2004037800A1 Aryloxyalkylamine derivates as h3 receptor ligands |
| 05/06/2004 | WO2004037797A2 2 - alkyl - (2 - amino - 3 - aryl - propionyl) - piperazine derivatives and related compounds as melanocortin receptor ligands for the treatment of obesity |
| 05/06/2004 | WO2003084942A3 Stereoselective alkylation of chiral 2-methyl-4-protected piperazines |
| 05/06/2004 | WO2003040096A3 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 05/06/2004 | US20040087627 Decarboxylase inhibitors; cardiovascular diosrders; antidiabetic agents; anticancer agents; dietetics |
| 05/06/2004 | US20040087620 Terphenyl compounds bearing substituted amino groups |
| 05/06/2004 | US20040087588 Parp inhibitors |
| 05/06/2004 | US20040087585 Peptide deformylase inhibitors |
| 05/06/2004 | US20040087582 Anticaogulants; cardiovascular disorders; Factor x inhibitors; antiinflammatory agents |
| 05/06/2004 | US20040087581 Heterocyclylalkylamines as muscarinic receptor antagonists |
| 05/06/2004 | US20040087491 Electrophilic ketones for the treatment of herpesvirus infections |
| 05/06/2004 | EP1414801A1 Arylamines for the treatment of conditions associated with gsk-3 |
| 05/06/2004 | EP1414795A1 Bicyclic modulators of androgen receptor function |
| 05/06/2004 | EP1163237B1 Amide derivatives |
| 05/06/2004 | EP0960106B1 1-phenyl-4-benzylpiperazines: dopamine receptor subtype specific ligands (d4) |
| 05/06/2004 | CA2501231A1 2-alkyl-(2-amino-3-aryl-propionyl)-piperazine derivatives and related compounds as melanocortin receptor ligands for the treatment of obesity |
| 05/05/2004 | CN1494539A Antagonists of MCP-1 function and methods of use thereof |
| 05/05/2004 | CN1494533A Process for enhancement of cycle life of zinc chromium based catalyst used in synthesis of 2-methyl pyrazine |
| 05/05/2004 | CN1148178C Mixtures separated from seeds of syzygium, preparations thereof, and uses as medicines containing them and components therefrom |
| 04/29/2004 | WO2004006354A3 Polymeric charge transport compositions and electronic devices made with such compositions |
| 04/29/2004 | WO2003093242A3 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade |
| 04/29/2004 | WO2003086282A3 Nitric oxide donors, compositions and methods of use |
| 04/29/2004 | WO2002102787A3 Novel sulfonic acid derivatives |
| 04/29/2004 | US20040083447 1-Phenyl-4-benzylpiperazines dopamine receptor subtype specific ligands |
| 04/29/2004 | US20040082780 Vanilloid receptor ligands and their use in treatments |
| 04/29/2004 | US20040082628 Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 04/29/2004 | US20040082627 Certain aromatic monocycles as kinase modulators |
| 04/29/2004 | US20040082625 Osteoporosis, bone disorders |
| 04/29/2004 | US20040082585 Anticoagulants; controlling thrombosis; cardiovascular disorders |
| 04/29/2004 | US20040082553 Novel florfenicol-type antibiotics |
| 04/29/2004 | US20040082497 For treatment of growth hormone deficiency/polycystic ovary syndrome autoimmune/inflammatory disease |
| 04/28/2004 | EP1412325A1 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes |
| 04/28/2004 | EP1411948A1 Tetrahydroquinoxalines acting as bradykinin antagonists |
| 04/28/2004 | CN1491945A Process for preparing human immunodeficiency virus (HIV) proteinase inhibitor |
| 04/28/2004 | CN1491937A 农药 Pesticide |
| 04/27/2004 | US6727368 Oligomers and polymers of cyclic imino carboxylic acids |
| 04/22/2004 | WO2003041728A9 Novel phenyl-propargylether derivatives |
| 04/22/2004 | US20040077860 Quinoxaline derivative; light-emitting diode, light-emitting electrochemical cell, or a photodetector |
| 04/22/2004 | US20040077671 Sorbitol dehydrogenase inhibitors |
| 04/22/2004 | US20040077646 Indole nitriles |
| 04/22/2004 | US20040077600 Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease |
| 04/22/2004 | US20040077528 Entrapping active agent in fumaryl diketopiperazine derivative and solvent washing out impurities; purified insulin for pulmonary administration |
| 04/21/2004 | EP1409691A2 Stereoselective preparation of cyclic l-amino acids |
| 04/21/2004 | EP1409468A2 Guanidinobenzamides as mc4-r agonists |
| 04/21/2004 | EP1409456A2 Detection of transmembrane potentials by optical methods |
| 04/21/2004 | EP1409450A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 04/21/2004 | EP1409440A1 A method to inhibit ethylene responses in plants |
| 04/21/2004 | EP1408986A2 Proteomimetic compounds and methods |
| 04/21/2004 | CN1491208A Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical |
| 04/21/2004 | CN1491207A Acylated indanyl amines and their use as pharmaceuticals |
| 04/21/2004 | CN1146542C Benzamide derivatives and their use as cytokine inhibitors |
| 04/20/2004 | US6723730 Capsaicin receptor ligands |
| 04/20/2004 | US6723445 Organic light-emitting devices |
| 04/15/2004 | WO2004031161A1 Neurologically-active compounds |
| 04/15/2004 | WO2004030635A2 Vasculostatic agents and methods of use thereof |
| 04/15/2004 | WO2004018436A3 Compounds derived from aryl carbamates, preparation thereof and uses of same |
| 04/15/2004 | WO2003106381A3 Human adam-10 inhibitors |
| 04/15/2004 | US20040072880 Cycloalkyl inhibitors of potassium channel function |
| 04/15/2004 | US20040072860 Piperazin-2-one amides as inhibitors of factor xa |
| 04/15/2004 | US20040072854 Antiemetics; psychlogical disorders; antidepressants; anxiolytic agents; antitussive agents |
| 04/15/2004 | US20040072834 Crystal forms of quinoxaline-2-carboxylic acid [4-carbamoyl-1-(3-fluorobenzyl)-2,7-dihydroxy-7-methyl-octyl]-amide |